Hyper Corporation

Hyper Corporation Change in Working Capital

The Change in Working Capital of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is -7.05 B KRW. In the previous year, Change in Working Capital was 659.91 M KRW — a change of -1,169.03% (lower).

Change in Working Capital

-7.05 BKRW

YoY

-1,169.03%

Last updated:

Change in Working Capital of Hyper Corporation is 2025 -7.05 B KRW. Change in Working Capital of Hyper Corporation was 2024 659.91 M KRW. It decreases by -1,169.03% lower compared to the previous year.

The Hyper Corporation Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2018
167.92 M KRW
Jan 1, 2019
-2.66 B KRW
Jan 1, 2020
3.18 B KRW
Jan 1, 2021
-4.82 B KRW
Jan 1, 2022
-179.31 M KRW
Jan 1, 2023
-2.46 B KRW
Jan 1, 2024
659.91 M KRW
Jan 1, 2025
-7.05 B KRW
The Hyper Corporation Change in Working Capital history
YEARChange in Working CapitalYoY
-7.05 BKRW-1,169.03%
659.91 MKRW-126.86%
-2.46 BKRW+1,270.33%
-179.31 MKRW-96.28%
-4.82 BKRW-251.63%
3.18 BKRW-219.50%
-2.66 BKRW-1,684.11%
167.92 MKRW-108.98%
-1.87 BKRW+95.69%
-955.31 MKRW+308.30%
-233.97 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Change in Working Capital of Hyper Corporation is -7.05 B KRW in 2025.

Change in Working Capital of Hyper Corporation changed from 659.91 M KRW to -7.05 B KRW, representing a -1,169.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hyper Corporation

All Key Metrics — Hyper Corporation